Sign in
4

Changes in Ownership

Guardant Health, Inc. Filed Acc 0001576280-25-000181

Director sold 2,626 shares at $49.70 ($130,512)

  • Director acquired 6,743 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

POTTER MYRTLE S · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-12 Exercise or conversion : show line 1 in the form 10b5-1 +6,674 20,737 D
2025-06-15 Exercise or conversion : show line 2 in the form 10b5-1 +69 20,806 D
2025-06-16 Sale : show line 3 in the form 10b5-1 −2,626 $49.70 $130,512 18,180 D
Open-market sales · 2,626 sh · avg $49.70 · $130,512

Table II: Derivative

2 lines
Date Transaction Shares Exercise Underlying Owned after D/I
2025-06-12 Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Units −6,674 $0.00 6,674 0 D
2025-06-15 Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Units −69 $0.00 69 274 D
Loading xslF345X05/wk-form4_1750116528.xml…